Jörg Pabel

531 total citations
27 papers, 397 citations indexed

About

Jörg Pabel is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Jörg Pabel has authored 27 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 12 papers in Cellular and Molecular Neuroscience and 10 papers in Molecular Biology. Recurrent topics in Jörg Pabel's work include Neuroscience and Neuropharmacology Research (9 papers), Chemical Synthesis and Analysis (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Jörg Pabel is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Chemical Synthesis and Analysis (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Jörg Pabel collaborates with scholars based in Germany, Italy and Poland. Jörg Pabel's co-authors include Klaus T. Wanner, Georg Höfner, Lars Allmendinger, Κ. Polborn, Thomas Wein, Cornelia E. Hoesl, Julien Dine, Matthias Eder, Markus Ege and Julian A. Marschner and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Jörg Pabel

24 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Pabel Germany 13 171 171 161 53 43 27 397
Stanislas Mayer France 12 240 1.4× 201 1.2× 88 0.5× 67 1.3× 29 0.7× 20 475
F. Moureau Belgium 9 216 1.3× 154 0.9× 143 0.9× 26 0.5× 27 0.6× 17 512
Vivian W. Y. Liao Australia 11 202 1.2× 233 1.4× 114 0.7× 28 0.5× 16 0.4× 23 536
Masaki Suzuki Japan 17 246 1.4× 274 1.6× 106 0.7× 25 0.5× 69 1.6× 32 663
Niall M. Hamilton United Kingdom 13 143 0.8× 240 1.4× 111 0.7× 18 0.3× 17 0.4× 30 467
Thomas J. Bleisch United States 10 167 1.0× 222 1.3× 195 1.2× 15 0.3× 40 0.9× 14 432
Behrend F. Lundt Denmark 11 160 0.9× 373 2.2× 143 0.9× 24 0.5× 65 1.5× 11 578
Frank A. Sløk Denmark 14 200 1.2× 305 1.8× 161 1.0× 22 0.4× 44 1.0× 26 471
William D. Shipe United States 10 241 1.4× 243 1.4× 158 1.0× 18 0.3× 14 0.3× 13 497
David Wensbo Sweden 15 328 1.9× 189 1.1× 128 0.8× 40 0.8× 23 0.5× 18 616

Countries citing papers authored by Jörg Pabel

Since Specialization
Citations

This map shows the geographic impact of Jörg Pabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Pabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Pabel more than expected).

Fields of papers citing papers by Jörg Pabel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Pabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Pabel. The network helps show where Jörg Pabel may publish in the future.

Co-authorship network of co-authors of Jörg Pabel

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Pabel. A scholar is included among the top collaborators of Jörg Pabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Pabel. Jörg Pabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Marie‐Louise, Kinga Sałat, Georg Höfner, et al.. (2025). Synthesis and Biological Evaluation of Nipecotic Acid Derivatives with Terminally Double-Substituted Allenic Spacers as mGAT4 Inhibitors. Journal of Medicinal Chemistry. 68(19). 19984–20010.
2.
Marschner, Julian A., et al.. (2024). Automated design of multi-target ligands by generative deep learning. Nature Communications. 15(1). 7946–7946. 11 indexed citations
3.
Pabel, Jörg, et al.. (2024). Tuning RXR Modulators for PGC1α Recruitment. Journal of Medicinal Chemistry. 67(18). 16338–16354.
4.
Willems, Sabine, et al.. (2024). Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism. Journal of Medicinal Chemistry. 67(15). 13324–13348. 4 indexed citations
5.
Höfner, Georg, et al.. (2023). Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole. Journal of Medicinal Chemistry. 66(19). 13556–13567. 7 indexed citations
6.
Gege, Christian, Hella Kohlhof, Georg Höfner, et al.. (2023). Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Journal of Medicinal Chemistry. 66(9). 6391–6402. 23 indexed citations
7.
Schubert‐Zsilavecz, Manfred, et al.. (2023). Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency. Journal of Medicinal Chemistry. 66(24). 16762–16771. 8 indexed citations
8.
Pabel, Jörg, et al.. (2019). Synthesis and biological evaluation of fluorescent GAT-ligands based on meso-substituted BODIPY dyes. Medicinal Chemistry Research. 29(2). 301–327. 7 indexed citations
9.
Wein, Thomas, Georg Höfner, Jörg Pabel, et al.. (2018). Development of New Photoswitchable Azobenzene Based γ-Aminobutyric Acid (GABA) Uptake Inhibitors with Distinctly Enhanced Potency upon Photoactivation. Journal of Medicinal Chemistry. 61(14). 6211–6235. 16 indexed citations
10.
Sałat, Kinga, Adrian Podkowa, Natalia Malikowska‐Racia, et al.. (2016). Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties. Neuropharmacology. 113(Pt A). 331–342. 35 indexed citations
11.
Jakubowska, Anna, et al.. (2014). Asymmetric synthesis of all four stereoisomers of 1-amino-3-hydroxy-cyclopentane-1-carboxylic acid. Tetrahedron. 71(4). 686–693. 3 indexed citations
12.
Höfner, Georg, et al.. (2014). First Photoswitchable Neurotransmitter Transporter Inhibitor: Light-Induced Control of γ-Aminobutyric Acid Transporter 1 (GAT1) Activity in Mouse Brain. Journal of Medicinal Chemistry. 57(15). 6809–6821. 31 indexed citations
13.
Zhao, Xueqing, Jörg Pabel, Georg Höfner, & Klaus T. Wanner. (2012). Synthesis and biological evaluation of 4-hydroxy-4-(4-methoxyphenyl)-substituted proline and pyrrolidin-2-ylacetic acid derivatives as GABA uptake inhibitors. Bioorganic & Medicinal Chemistry. 21(2). 470–484. 3 indexed citations
14.
15.
Höfner, Georg, et al.. (2011). Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors. European Journal of Medicinal Chemistry. 46(5). 1483–1498. 19 indexed citations
16.
Höfner, Georg, et al.. (2010). Azetidine derivatives as novel γ-aminobutyric acid uptake inhibitors: Synthesis, biological evaluation, and structure–activity relationship. European Journal of Medicinal Chemistry. 45(6). 2453–2466. 30 indexed citations
17.
18.
Pabel, Jörg, et al.. (2009). Asymmetric Synthesis of Pyrido[1,2-c]pyrimidinones. Zeitschrift für Naturforschung B. 64(6). 653–661.
19.
Wanner, Klaus T., Cornelia E. Hoesl, Jörg Pabel, & Κ. Polborn. (2002). Synthesis of Sterically Demanding 3-Silylpyridines and Their Use in Asymmetric Synthesis with Chiral N-Acyliminium Ions. Heterocycles. 58(1). 383–383. 6 indexed citations
20.
Pabel, Jörg, Georg Höfner, & Klaus T. Wanner. (2000). Synthesis and resolution of racemic eliprodil and evaluation of the enantiomers of eliprodil as NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(12). 1377–1380. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanislas Mayer Breakdown of academic impact, for papers by F. Moureau Breakdown of academic impact, for papers by Vivian W. Y. Liao Breakdown of academic impact, for papers by Masaki Suzuki Breakdown of academic impact, for papers by Niall M. Hamilton Breakdown of academic impact, for papers by Thomas J. Bleisch Breakdown of academic impact, for papers by Behrend F. Lundt Breakdown of academic impact, for papers by Frank A. Sløk Breakdown of academic impact, for papers by William D. Shipe Breakdown of academic impact, for papers by David Wensbo
Rankless by CCL
2026